New study published demonstrating the utility of PromarkerD test

August 2, 2022 Australian Biotech

This is a preview of subscriber content

Subscribe now to continue reading.

Proteomics International Laboratories (ASX:PIQ) has announced that a study demonstrating the clinical utility of the PromarkerD test in predicting diabetic kidney disease has been published in the journal PLOS ONE. …

Subscribe now to continue reading.

Latest Video

New Stories

Coalition turns debate on cheaper medicines Bill to HTA reform delays
August 27, 2025 - - Latest News
Pharmacy Guild showcases more accessible healthcare for women
August 27, 2025 - - Latest News
Sandoz pushes for biosimilar reform while building a great workplace
August 27, 2025 - - Latest News
Cartherics secures Chinese patent to boost immune cell function in solid tumours
August 27, 2025 - - Australian Biotech
NeuroScientific’s StemSmart MSC therapy shows promise in kidney transplantation
August 27, 2025 - - Australian Biotech
Starpharma advances dendrimer platform with clinical, commercial, and strategic progress
August 27, 2025 - - Australian Biotech
Biome achieves breakthrough year with first profit and rapid global expansion
August 27, 2025 - - Australian Biotech

New study published demonstrating the utility of PromarkerD test

This is a preview of subscriber content

Latest Video

Most Read

Mark Butler asking questions about Trump's 'Most Favored Nation' pricing push

'Patients can’t wait – swift action and access are the only possible moves from here'

Government and Coalition combine to defeat Moderna agreement motion

Australians are rapidly increasing their adoption of AI, including for healthcare

Bristol Myers Squibb launches cancer resources for First Nations Australians

New Stories

Coalition turns debate on cheaper medicines Bill to HTA reform delays

Pharmacy Guild showcases more accessible healthcare for women

Sandoz pushes for biosimilar reform while building a great workplace

Cartherics secures Chinese patent to boost immune cell function in solid tumours

NeuroScientific’s StemSmart MSC therapy shows promise in kidney transplantation

Starpharma advances dendrimer platform with clinical, commercial, and strategic progress

Biome achieves breakthrough year with first profit and rapid global expansion

Sign In

New study published demonstrating the utility of PromarkerD test

This is a preview of subscriber content

Latest Video

Most Read

Mark Butler asking questions about Trump's 'Most Favored Nation' pricing push

'Patients can’t wait – swift action and access are the only possible moves from here'

Government and Coalition combine to defeat Moderna agreement motion

Australians are rapidly increasing their adoption of AI, including for healthcare

Bristol Myers Squibb launches cancer resources for First Nations Australians

Follow Us

New Stories

Coalition turns debate on cheaper medicines Bill to HTA reform delays

Pharmacy Guild showcases more accessible healthcare for women

Sandoz pushes for biosimilar reform while building a great workplace

Cartherics secures Chinese patent to boost immune cell function in solid tumours

NeuroScientific’s StemSmart MSC therapy shows promise in kidney transplantation

Starpharma advances dendrimer platform with clinical, commercial, and strategic progress

Biome achieves breakthrough year with first profit and rapid global expansion